NeuroInDx receives NIH/NCRR SBIR Phase II award to further develop and commercialize low cost cell and tissue acquisition system (CTAS).
-
Recent News
- NeuroInDx completes NIH SBIR Commercialization Assistance Program
- 232
- NeuroInDx receives fourth NIH/NIMH SBIR Phase I award
- NIH SBIR Commercialization Assistance Program
- Society for Neuroscience’s 40th Annual Meeting – San Diego
- American Neurological Association’s 135th Annual Meeting in San Francisco, CA
- NeuroInDx’s FAST-MD concept
- NeuroInDx receives NIH/NCRR SBIR Phase II award
- Experimental Biology
- Epilepsy Pipeline Update